Insulin, proinsulin, glucagon and gastrin in pancreatic tumors and in plasma of patients with organic hyperinsulinism.
about
Reduction of insulin resistance with effective clearance of hepatitis C infection: results from the HALT-C trialThe value of artificial beta cell in the management of insulinoma.Gut-hormone profile in totally pancreatectomised patientsHyperuricemia in glycogen storage disease type I. Contributions by hypoglycemia and hyperglucagonemia to increased urate production.Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trialDiagnosis of Zollinger-Ellison syndrome: increasingly difficult.Regulation of obese (ob) mRNA and plasma leptin levels in rhesus monkeys. Effects of insulin, body weight, and non-insulin-dependent diabetes mellitus.Prevention of obesity in middle-aged monkeys: food intake during body weight clamp.Insulin, glucagon and somatostatin stores in the pancreas of subjects with type-2 diabetes and their lean and obese non-diabetic controls.Diversity of insulin resistance in monkeys with normal glucose tolerance.Monkey leptin receptor mRNA: sequence, tissue distribution, and mRNA expression in the adipose tissue of normal, hyperinsulinemic, and type 2 diabetic rhesus monkeys.Septic Shock Non-Survivors have Persistently Elevated Acylcarnitines Following Carnitine Supplementation.Diagnosis of Zollinger-Ellison syndrome in the era of PPIs, faulty gastrin assays, sensitive imaging and limited access to acid secretory testing.Antihypertensive effects of captopril without adverse effects on glucose tolerance in hyperinsulinemic rhesus monkeys.Correlates of the estimated arterial compliance in the population of Tecumseh, Michigan.Inhibited amino acid uptake in skeletal muscle during starvation.Metabolic profiles in patients with insulinoma.Rapid fluctuations in plasma catecholamines in monkeys under undisturbed conditions.Neural influences on oscillations in basal plasma levels of insulin in monkeys.
P2860
Q33798375-1D139D01-4AEE-4EF2-8BD2-DF91C39870E6Q34112132-B4DA5423-EEF2-4A94-96AB-221141A11FAAQ34493632-79BCE2F2-C5E0-4234-AF5A-45BEDFF30024Q34524420-1ED20073-9A9C-4688-BFEB-04195C52AF6AQ35142681-366F8DDF-36DB-4F57-BF61-215C666535CAQ36351873-42577207-CF30-49A3-9351-20442002E9B6Q38352381-9208B389-860B-499A-A7BF-4A676A35777DQ40958687-4BEDFD3A-6701-4F49-869F-23315C285FDAQ41480990-0D3306E3-1A23-42A6-B5ED-39B697F43FA2Q42487947-84963ACC-493E-4E10-903F-871B871968A4Q48395333-59C3B194-2F60-47D6-B606-E473566292CCQ49561103-02E950EA-BCDF-449B-86FC-884E74CDF502Q50075239-E4802B4E-98D9-4C67-A6D3-8E2C652326DBQ51592319-B695715E-D093-4742-B283-646133E4AE66Q51605961-7D88F86B-698B-4C30-8484-9B95D0CBD106Q51620261-F396E0E2-6AE2-4A50-83BA-6C72C5F11275Q51623385-237B8EF2-DC15-4DA1-AF78-1627C9D9201BQ51652766-7AD7BDC8-7FF0-44A2-919C-9AE122E405E1Q51871115-36DB5D84-DCBF-4177-A784-B0BD68B54FC9
P2860
Insulin, proinsulin, glucagon and gastrin in pancreatic tumors and in plasma of patients with organic hyperinsulinism.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
1977年论文
@zh
1977年论文
@zh-cn
name
Insulin, proinsulin, glucagon ...... with organic hyperinsulinism.
@en
Insulin, proinsulin, glucagon ...... with organic hyperinsulinism.
@nl
type
label
Insulin, proinsulin, glucagon ...... with organic hyperinsulinism.
@en
Insulin, proinsulin, glucagon ...... with organic hyperinsulinism.
@nl
prefLabel
Insulin, proinsulin, glucagon ...... with organic hyperinsulinism.
@en
Insulin, proinsulin, glucagon ...... with organic hyperinsulinism.
@nl
P2093
P356
P1476
Insulin, proinsulin, glucagon ...... with organic hyperinsulinism.
@en
P2093
P304
P356
10.1210/JCEM-44-4-681
P407
P577
1977-04-01T00:00:00Z